81 related articles for article (PubMed ID: 28481789)
1. Comparison of the 68Ga-DOTATATA PET/CT, FDG PET/CT, and MIBG SPECT/CT in the Evaluation of Suspected Primary Pheochromocytomas and Paragangliomas.
Jing H; Li F; Wang L; Wang Z; Li W; Huo L; Zhang J
Clin Nucl Med; 2017 Jul; 42(7):525-529. PubMed ID: 28481789
[TBL] [Abstract][Full Text] [Related]
2. Head-to-head comparison between [
He Q; Zhang Z; Zhang L; Zhang B; Long Y; Zhang Y; Liao Z; Zha Z; Zhang X
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1989-2001. PubMed ID: 38300262
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of [
Jha A; Patel M; Ling A; Shah R; Chen CC; Millo C; Nazari MA; Sinaii N; Charles K; Kuo MJM; Prodanov T; Saboury B; Talvacchio S; Derkyi A; Del Rivero J; O'Sullivan Coyne G; Chen AP; Nilubol N; Herscovitch P; Lin FI; Taieb D; Civelek AC; Carrasquillo JA; Pacak K
Eur Radiol; 2024 Apr; ():. PubMed ID: 38625612
[TBL] [Abstract][Full Text] [Related]
4. Imaging of Pheochromocytomas and Paragangliomas.
Timmers HJLM; Taïeb D; Pacak K; Lenders JWM
Endocr Rev; 2024 May; 45(3):414-434. PubMed ID: 38206185
[TBL] [Abstract][Full Text] [Related]
5. Management of Abdominal Paraganglioma: A Single Center's Experience.
Battistella E; Pomba L; Mirabella M; Toniato R; Opocher G; Toniato A
Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674250
[No Abstract] [Full Text] [Related]
6. 3-[
Else T; Wong KK; Frey KA; Brooks AF; Viglianti BL; Raffel DM
J Endocr Soc; 2024 Apr; 8(6):bvae049. PubMed ID: 38617812
[TBL] [Abstract][Full Text] [Related]
7. PET/CT and SPECT/CT for Infection in Joints and Bones: An Overview and Future Directions.
Mokoala KMG; Ndlovu H; Lawal I; Sathekge MM
Semin Nucl Med; 2024 May; 54(3):394-408. PubMed ID: 38016897
[TBL] [Abstract][Full Text] [Related]
8. Nuclear medicine practice in Japan: a report of the ninth nationwide survey in 2022.
Okizaki A; Nishiyama Y; Inui Y; Otsuka H; Takanami K; Nakajo M; Nakatani K; Nogami M; Hirata K; Maeda Y; Yoshimura M; Wakabayashi H
Ann Nucl Med; 2024 Apr; 38(4):315-327. PubMed ID: 38421515
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of multiple-dose versus single-dose MIBG therapy in patients with refractory pheochromocytoma and paraganglioma: a single-center retrospective analysis.
Wakabayashi N; Watanabe S; Abe T; Takenaka J; Hirata K; Kimura R; Sakamoto K; Shinohara N; Kudo K
Ann Nucl Med; 2024 Apr; ():. PubMed ID: 38656630
[TBL] [Abstract][Full Text] [Related]
10. Approach to the patient: Concept and application of targeted radiotherapy in the paraganglioma patient.
Pacak K; Taieb D; Lin FI; Jha A
J Clin Endocrinol Metab; 2024 Apr; ():. PubMed ID: 38652045
[TBL] [Abstract][Full Text] [Related]
11. Radio theranostics in paragangliomas and pheochromocytomas.
Prado Wohlwend S; Bello Arques P;
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024 May; ():500017. PubMed ID: 38735639
[TBL] [Abstract][Full Text] [Related]
12. Incomplete resection in a rare case of bladder paraganglioma revealed by diuretic
Padilla Bermejo A; Gatón Ramírez J; Pena Pardo FJ; Sicilia Pozo MLN; Talavera Rubio MDP; Poblete García V
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024 May; ():500018. PubMed ID: 38821408
[No Abstract] [Full Text] [Related]
13. Differentiation of vagal from carotid paraganglioma on unenhanced PET/CT: the "sweet potato" shape on PET.
Varoquaux A; Fakhry N; Scemama U; Taïeb D
Eur J Nucl Med Mol Imaging; 2024 Jun; ():. PubMed ID: 38829375
[No Abstract] [Full Text] [Related]
14. Current Concepts in
Bodei L; Ambrosini V; Herrmann K; Modlin I
J Nucl Med; 2017 Nov; 58(11):1718-1726. PubMed ID: 28818983
[No Abstract] [Full Text] [Related]
15. 18F-FDOPA PET/CT Imaging of MAX-Related Pheochromocytoma.
Taïeb D; Jha A; Guerin C; Pang Y; Adams KT; Chen CC; Romanet P; Roche P; Essamet W; Ling A; Quezado MM; Castinetti F; Sebag F; Pacak K
J Clin Endocrinol Metab; 2018 Apr; 103(4):1574-1582. PubMed ID: 29534198
[TBL] [Abstract][Full Text] [Related]
16. Superiority of
Jha A; Ling A; Millo C; Gupta G; Viana B; Lin FI; Herscovitch P; Adams KT; Taïeb D; Metwalli AR; Linehan WM; Brofferio A; Stratakis CA; Kebebew E; Lodish M; Civelek AC; Pacak K
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):787-797. PubMed ID: 29204718
[TBL] [Abstract][Full Text] [Related]
17. Role of DOTATATE-PET/CT in preoperative assessment of phaeochromocytoma and paragangliomas.
Gild ML; Naik N; Hoang J; Hsiao E; McGrath RT; Sywak M; Sidhu S; Delbridge LW; Robinson BG; Schembri G; Clifton-Bligh RJ
Clin Endocrinol (Oxf); 2018 Aug; 89(2):139-147. PubMed ID: 29741215
[TBL] [Abstract][Full Text] [Related]
18. New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma.
Taïeb D; Pacak K
Trends Endocrinol Metab; 2017 Nov; 28(11):807-817. PubMed ID: 28867159
[TBL] [Abstract][Full Text] [Related]
19. Update on Modern Management of Pheochromocytoma and Paraganglioma.
Lenders JWM; Eisenhofer G
Endocrinol Metab (Seoul); 2017 Jun; 32(2):152-161. PubMed ID: 28685506
[TBL] [Abstract][Full Text] [Related]
20. The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers.
Rijken JA; Niemeijer ND; Jonker MA; Eijkelenkamp K; Jansen JC; van Berkel A; Timmers HJLM; Kunst HPM; Bisschop PHLT; Kerstens MN; Dreijerink KMA; van Dooren MF; van der Horst-Schrivers ANA; Hes FJ; Leemans CR; Corssmit EPM; Hensen EF
Clin Genet; 2018 Jan; 93(1):60-66. PubMed ID: 28503760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
